Johns Hopkins Medicine

A simple blood test may soon help precisely identify your risk for Alzheimer’s disease by inducing some of your cells to go back in time, looking like they did when you were an embryo. Johns Hopkins cell engineering expert Vasiliki …

What might reprogramming cells have to do with understanding Alzheimer’s? Elizabeth Tracey reports Read more →

This podcast is the first of a three part series: Nursing Grand Rounds (NGR) at Hopkins. NGR is a new initiative that fosters excellence in nursing practice by creating a dedicated space for professional learning. NGR launched at Howard County Medical Center with …

Episode 76: Nursing Grand Rounds –Supporting Antenatal Milk Expression | Johns Hopkins Center for Nursing Inquiry Read more →

What’s normal aging vs. dementia? In this episode of Medicine Made General, Dr. Ravi Gupta goes into detail on what the term “dementia” means, how it differs from normal forgetfulness, and why dementia is more than just memory loss.

Hormone therapy for menopause has recently had a black box warning removed by the FDA, after the agency reexamined data originally prompting the warning and found it flawed. Wen Shen, a menopause expert at Johns Hopkins, says women still need …

Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports Read more →

The FDA has recently removed black box warnings, indicating a medication is potentially risky, from hormone therapy for menopause. The warning was originally put on in 2003 after a study seemed to show increased risks for cardiovascular disease, breast cancer …

What is the controversy around hormone therapy for menopause? Elizabeth Tracey reports Read more →

If you’re a woman who’s experiencing a loss of libido, you may have been advised to take testosterone supplements, but Wen Shen, a menopause expert at Johns Hopkins, says wholesale embrace of hormone therapy isn’t for everyone, in spite of …

Women need to exercise caution when it comes to hormones of all types, Elizabeth Tracey reports Read more →

Hormone therapy is not a panacea for everything that happens to a women transitioning through menopause, cautions Wen Shen, a menopause expert at Johns Hopkins. Now that the FDA has removed their black box warning from many forms of hormone …

What are the benefits of hormone therapy for women in menopause and perimenopause? Elizabeth Tracey reports Read more →

Certain hormone therapies for menopause have had black box warnings on them since 2003, following concerns arising from the Women’s Health Initiative study, which seemed to show increased risks for breast cancer and dementia. Now the FDA has removed these …

What might the FDA’s removal of a black box warning on hormone therapy for menopause mean to you? Elizabeth Tracey reports Read more →

Using one of two drug combinations versus ibrutinib alone to treat chronic lymphocytic leukemia, one of the most common types of leukemia in adults, may allow people to avoid continuous treatment, a new study finds.  William Nelson, director of the Kimmel …

A couple new approaches to treating a type of leukemia may help shorten treatment, Elizabeth Tracey reports Read more →

For people who’ve had colorectal cancer, celecoxib, a commonly prescribed medicine for pain, may help avoid disease recurrence, a recent analysis of a larger study found. Kimmel Cancer Center director William Nelson at Johns Hopkins explains that the presence of …

Can the drug celecoxib help some people avoid colorectal cancer recurrence? Elizabeth Tracey reports Read more →